510(k) K162275

Randox RX Daytona Plus Alkaline Phosphatase (ALP) by Randox Laboratories Limited — Product Code CJE

K162275 is an FDA 510(k) premarket notification submitted by Randox Laboratories Limited for the device "Randox RX Daytona Plus Alkaline Phosphatase (ALP)". The FDA issued a decision of Substantially Equivalent on April 21, 2017. The device falls under product code CJE (Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes), a Class II device regulated under 21 CFR 862.1050. Randox Laboratories Limited has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 21, 2017
Date Received
August 12, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes
Device Class
Class II
Regulation Number
862.1050
Review Panel
CH
Submission Type